 |
|
PNAS study reveals why organs fail following massive trauma
October 18, 2006National research effort addresses No. 1 cause of death among young people
Massive trauma, say from a sabertooth tiger attack, meant immediate death for the primitive human. Modern man is more likely to survive severe injury caused by a car crash, gunshot or fall thanks to high-tech emergency medicine. Unfortunately, the body does not know what to do when it survives an injury that would have been fatal until recently in human evolution. Nearly one third of the time, mechanisms in place to protect people from disease misfire seven to ten days after severe injury, causing multiple organ failure. That is one reason why trauma is the leading cause of death for Americans aged 44 and younger.
A nationwide team of researchers is working urgently on the problem of post-trauma immune system and organ failure, and has discovered several new biochemical pathways that play a central role, according to a study published today in the Proceedings of the National Academy of Sciences (PNAS). Inventing new techniques along the way, the team is changing emergency room guidelines, building the foundation for earlier diagnosis of post-trauma organ failure and making possible the design of drugs to reverse it.
Trauma has become a federal research priority because the survival rate has not improved in 10 years. Excitement is growing, however, because new evidence suggests that major diseases involving the immune system share some of the same mechanisms and may be cured by manipulating the same molecules. A protein called programmed cell death 1 (PD1), for example, suggested by the PNAS paper as playing a role in post-trauma organ failure, is also involved in the immune system breakdown leading to AIDS, according to an article in the August edition of Nature.
"Our study proves for the first time that it is possible to identify the genetic and protein changes in specific immune cells that play a significant role in determining whether or not trauma is fatal," said Carol L. Miller-Graziano, Ph.D., professor of Surgery and of Microbiology & Immunology at the University of Rochester Medical Center, and an author of the PNAS study. "Beyond trauma, we believe that the techniques established here can provide insights into many disease that involve human immune system failure."
No Respite from Toxins
The human immune system is actually two systems developed at different points in human evolution. White blood cells of the more primitive innate system, like neutrophils and macrophages, form the first line of defense against disease. They swarm to the injury to engulf and destroy bacteria with toxic molecules and biochemicals. Because these same molecules and chemicals are also toxic to nearby human cells, the innate response is normally shut down quickly by the onset of the more time-consuming, precise and thorough adaptive immune system.
This second system pumps out an endless variety of immune cells on the hope that one or more will be the right shape to link up with, and become activated by, any invader encountered. When one of those immune cells, called lymphocytes, recognizes a bacterium or virus presented by the innate system, that lymphocyte expands into army of clones specifically designed to attack the invader at hand. Unfortunately, lymphocytes too are capable of mistakenly destroying human cells. Thus, they have developed quality control mechanisms where they can choose to stop expanding into an army (anergy) or to commit suicide (apoptosis).
The PNAS study offers new evidence that an overwhelming wave of biochemical signals created by the innate response after massive trauma can mistakenly trigger anergy and apoptosis, especially in T cell lymphocytes, shutting down the adaptive response before it can begin. Without the normal transition, the innate system continues to pump out toxic chemicals (cytokines) and molecules (free radicals) that tear at organs until they fail.
The goal of the current study was to identify the few genes and proteins that play a central role in T-cell mediated immune and organ failure. Given that severe trauma effects as many as 20 percent of the 20,000 or so human genes, finding the genes and proteins involved in T cell anergy and apoptosis amid this storm has been a challenge.
Researchers took blood samples from 22 healthy subjects, and from 18 consenting patients who had experienced severe trauma, and were in the midst of organ failure. The team then used unique, clinically applicable techniques to separate out each immune cell type in the patients' blood into pure samples for study. Only when researchers compared pure samples of the same immune cell types (e.g. T cells to T cells) did meaningful patterns emerge. The authors achieved a statistically significant picture of the differences between traumatized and healthy patients for the first time, and despite skeptics that said it could not be done.
With pure samples in hand, researchers used microarray technology to generate a long list of genes that change when a person undergoes massive trauma. They then ran that list through a database of genetic information to see which of the genes changed by trauma were listed in the literature as having a role in T cell function. What emerged was a map of the likely functions of hundreds of genes and proteins related to T cell post-trauma dysfunction, and their likely partners in signaling pathways. The final step was to demonstrate that the proteins associated with those genes have an actual role in organ failure via real-world biochemical tests.
Results showed that the expression of nearly 5,700 genes related to T cell function is changed in cases of massive trauma, as are 2800 genes related to the function of macrophages, partnering immune cells necessary to T cell activation. Trauma had the most profound effect on just 338 of the genes, an at least two-fold change in their expression, the process by which the information they store is converted into proteins that carry out bodily functions. Post-traumatic genetic changes had two major effects on T cells: a marked increase in regulatory protein pathways that diminished their function, and a decrease in signals that turn them on, researchers said.
Whether T cells continue to multiply depends on the action of sensitive receptor proteins on their surfaces. Some of the receptors, once activated by signaling molecules, cause the T cell to multiply, while others stop the process or cause the cell to self-destruct. Researchers in the current study identified as many as 20 new receptors on the surfaces of T cells or signaling molecules within T cells, that increase their activity in the case of massive trauma to either cause anergy or apoptosis. Each pathway represents a target for the design of new drugs to reverse T cell shutdown.
The research for the current paper was conducted under the auspices of a Large-Scale Collaborative Award from the National Institute of General Medical Sciences (NIGMS), a division of the National Institutes of Health. Also called "Glue Grants," the awards bring together large teams of researchers to handle extremely complex problems. While the PNAS study patient sample was small, techniques based on it are now being used to study 150 patients per year throughout the Glue grant infrastructure. The glue grant is an open access endeavor as well. The results are posted publicly and hundreds of researchers have already accessed the PNAS study results and applied them to their own projects.
The grant is organized into seven research cores, with the PNAS study written within the Protein Analyses and Cell Biology (PACB) Core working closely with the Genomics Core. PACB include analytical sites, including the one led by Miller-Graziano. She oversaw the separation of white blood cells into pure samples for the PNAS study, and continues to determine cell surface protein expression for the larger Glue grant team.
Along with Miller-Graziano, the University of Rochester Medical Center team is led by Paul E. Bankey, M.D., Ph.D., director of Trauma and Critical Care in the Department of Surgery, and includes Asit De, Ph.D., assistant professor of surgery, and Krzysztof Laudanski, M.D., a post-doctoral fellow. Fifteen authors from eight universities and one pharmaceutical company collaborated on the PNAS article, including the Stanford Human Genome Center.
The trauma glue grant was launched in 2001 with an original $30 million award over five years, and has just been renewed with an additional $30 million in funding. The University of Rochester Medical Center team will receive about $3.9 million for its role between the two periods of the grant.
"These findings strikingly reveal that novel interactions among signaling pathways can be deconstructed in hospitalized patient populations," Bankey said. "For the first time, we can uncover changes in cells that tell us which patients are recovering, and which are getting worse, in almost any disease that involves the immune system."
University of Rochester Medical Center
Trauma has become a federal research priority because the survival rate has not improved in 10 years. Excitement is growing, however, because new evidence suggests that major diseases involving the immune system share some of the same mechanisms and may be cured by manipulating the same molecules. A protein called programmed cell death 1 (PD1), for example, suggested by the PNAS paper as playing a role in post-trauma organ failure, is also involved in the immune system breakdown leading to AIDS, according to an article in the August edition of Nature.
"Our study proves for the first time that it is possible to identify the genetic and protein changes in specific immune cells that play a significant role in determining whether or not trauma is fatal," said Carol L. Miller-Graziano, Ph.D., professor of Surgery and of Microbiology & Immunology at the University of Rochester Medical Center, and an author of the PNAS study. "Beyond trauma, we believe that the techniques established here can provide insights into many disease that involve human immune system failure."
No Respite from Toxins
The human immune system is actually two systems developed at different points in human evolution. White blood cells of the more primitive innate system, like neutrophils and macrophages, form the first line of defense against disease. They swarm to the injury to engulf and destroy bacteria with toxic molecules and biochemicals. Because these same molecules and chemicals are also toxic to nearby human cells, the innate response is normally shut down quickly by the onset of the more time-consuming, precise and thorough adaptive immune system.
This second system pumps out an endless variety of immune cells on the hope that one or more will be the right shape to link up with, and become activated by, any invader encountered. When one of those immune cells, called lymphocytes, recognizes a bacterium or virus presented by the innate system, that lymphocyte expands into army of clones specifically designed to attack the invader at hand. Unfortunately, lymphocytes too are capable of mistakenly destroying human cells. Thus, they have developed quality control mechanisms where they can choose to stop expanding into an army (anergy) or to commit suicide (apoptosis).
The PNAS study offers new evidence that an overwhelming wave of biochemical signals created by the innate response after massive trauma can mistakenly trigger anergy and apoptosis, especially in T cell lymphocytes, shutting down the adaptive response before it can begin. Without the normal transition, the innate system continues to pump out toxic chemicals (cytokines) and molecules (free radicals) that tear at organs until they fail.
The goal of the current study was to identify the few genes and proteins that play a central role in T-cell mediated immune and organ failure. Given that severe trauma effects as many as 20 percent of the 20,000 or so human genes, finding the genes and proteins involved in T cell anergy and apoptosis amid this storm has been a challenge.
Researchers took blood samples from 22 healthy subjects, and from 18 consenting patients who had experienced severe trauma, and were in the midst of organ failure. The team then used unique, clinically applicable techniques to separate out each immune cell type in the patients' blood into pure samples for study. Only when researchers compared pure samples of the same immune cell types (e.g. T cells to T cells) did meaningful patterns emerge. The authors achieved a statistically significant picture of the differences between traumatized and healthy patients for the first time, and despite skeptics that said it could not be done.
With pure samples in hand, researchers used microarray technology to generate a long list of genes that change when a person undergoes massive trauma. They then ran that list through a database of genetic information to see which of the genes changed by trauma were listed in the literature as having a role in T cell function. What emerged was a map of the likely functions of hundreds of genes and proteins related to T cell post-trauma dysfunction, and their likely partners in signaling pathways. The final step was to demonstrate that the proteins associated with those genes have an actual role in organ failure via real-world biochemical tests.
Results showed that the expression of nearly 5,700 genes related to T cell function is changed in cases of massive trauma, as are 2800 genes related to the function of macrophages, partnering immune cells necessary to T cell activation. Trauma had the most profound effect on just 338 of the genes, an at least two-fold change in their expression, the process by which the information they store is converted into proteins that carry out bodily functions. Post-traumatic genetic changes had two major effects on T cells: a marked increase in regulatory protein pathways that diminished their function, and a decrease in signals that turn them on, researchers said.
Whether T cells continue to multiply depends on the action of sensitive receptor proteins on their surfaces. Some of the receptors, once activated by signaling molecules, cause the T cell to multiply, while others stop the process or cause the cell to self-destruct. Researchers in the current study identified as many as 20 new receptors on the surfaces of T cells or signaling molecules within T cells, that increase their activity in the case of massive trauma to either cause anergy or apoptosis. Each pathway represents a target for the design of new drugs to reverse T cell shutdown.
The research for the current paper was conducted under the auspices of a Large-Scale Collaborative Award from the National Institute of General Medical Sciences (NIGMS), a division of the National Institutes of Health. Also called "Glue Grants," the awards bring together large teams of researchers to handle extremely complex problems. While the PNAS study patient sample was small, techniques based on it are now being used to study 150 patients per year throughout the Glue grant infrastructure. The glue grant is an open access endeavor as well. The results are posted publicly and hundreds of researchers have already accessed the PNAS study results and applied them to their own projects.
The grant is organized into seven research cores, with the PNAS study written within the Protein Analyses and Cell Biology (PACB) Core working closely with the Genomics Core. PACB include analytical sites, including the one led by Miller-Graziano. She oversaw the separation of white blood cells into pure samples for the PNAS study, and continues to determine cell surface protein expression for the larger Glue grant team.
Along with Miller-Graziano, the University of Rochester Medical Center team is led by Paul E. Bankey, M.D., Ph.D., director of Trauma and Critical Care in the Department of Surgery, and includes Asit De, Ph.D., assistant professor of surgery, and Krzysztof Laudanski, M.D., a post-doctoral fellow. Fifteen authors from eight universities and one pharmaceutical company collaborated on the PNAS article, including the Stanford Human Genome Center.
The trauma glue grant was launched in 2001 with an original $30 million award over five years, and has just been renewed with an additional $30 million in funding. The University of Rochester Medical Center team will receive about $3.9 million for its role between the two periods of the grant.
"These findings strikingly reveal that novel interactions among signaling pathways can be deconstructed in hospitalized patient populations," Bankey said. "For the first time, we can uncover changes in cells that tell us which patients are recovering, and which are getting worse, in almost any disease that involves the immune system."
University of Rochester Medical Center
Trauma Current Events and Trauma News RSSPossible Link Studied Between Childhood Abuse and Early Cellular Aging
Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University.
Engineer designs micro-endoscope to seek out early signs of cancer
Traditional endoscopes provide a peek inside patients' bodies. Now, a University of Florida engineering researcher is designing ones capable of a full inspection.
Drug studied as possible treatment for spinal injuries
Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed.
Pushing the brain to find new pathways
Until recently, scientists believed that, following a stroke, a patient had about six months to regain any lost function. After that, patients would be forced to compensate for the lost function by focusing on their remaining abilities.
Brain injured athletes may benefit from hypothermia research
NFL players and other athletes who suffer serious or multiple concussions may benefit from ground-breaking research being conducted by scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center. The scientists are developing a surgical technique that involves hypothermia in specific regions of the brain.
Continuous chest compression-CPR improved cardiac arrest survival in Arizona
The chance of surviving a cardiac arrest outside a hospital was found to be twice as high when bystanders performed continuous chest compressions without mouth-to-mouth breathing than when bystanders performed standard CPR.
Penn Study Provides First Clear Idea of How Rare Bone Disease Progresses
An international team of scientists, led by researchers at the University of Pennsylvania School of Medicine, is taking the first step in developing a treatment for a rare genetic disorder called fibrodysplasia ossificans progressiva (FOP), in which the body's skeletal muscles and soft connective tissue turns to bone, immobilizing patients over a lifetime with a second skeleton.
Psychiatric impact of torture could be amplified by head injury
Depression and other emotional symptoms in survivors of torture and other traumatic experiences may be exacerbated by the effects of head injuries, according to a study from the Harvard Program in Refugee Trauma (HPRT), based in the Massachusetts General Hospital (MGH) Department of Psychiatry.
NHLBI stops enrollment in study on resuscitation methods for cardiac arrest
Enrollment has ended early in a large, multicenter clinical trial comparing two distinct resuscitation strategies delivered by emergency medical service (EMS) providers to increase blood flow during cardiac arrest.
Researchers explore new ways to prevent spinal cord damage using a vitamin B3 precursor
Substances naturally produced by the human body may one day help prevent paralysis following a spinal cord injury, according to researchers at Weill Cornell Medical College. A recent $2.5 million grant from the New York State Spinal Cord Injury Research Board will fund their research investigating this possibility.
More Trauma Current Events and Trauma News Articles
 |
Trauma (Trauma (Moore)) by David Feliciano (Author), Kenneth Mattox (Author), Ernest Moore (Author) The most trusted, widely used guide to managing the trauma patient--now in a 2-color format with added algorithms A Doody's Core Title ESSENTIAL PURCHASE! 4 STAR DOODY'S REVIEW "This comprehensive text on trauma and its complications is an important treatise, which belongs in the library of all students, residents, and practitioners who care for or... |
 |
Trauma (Vintage Contemporaries) by Patrick McGrath (Author) Charlie Weir is a man who tackles other people's demons for a living. He has seen every kind of trauma during his years as a psychiatrist in New York.Yet he hasn't found a way of resolving his own conflicts, particularly the fatal mistake that caused his wife and daughter to leave him condemning him to corrosive loneliness and restless anger.Years later, he meets a beautiful but damaged woman who promises to restore his dwindling faith in both his profession and himself. But as he realizes that she has become more of a patient than a lover, events conspire to send him reeling toward the abyss. Addictive and enthralling, Trauma is Patrick McGrath's most riveting work to date. |
 |
Trauma Starring: Christopher Rydell, Asia Argento, Piper Laurie, Frederic Forrest, Laura Johnson Directed By: Dario Argento An anorexic young woman escapes from a psychiatric clinic and meets a young man who wants to help. She is caught and returned to her parents, who are soon beheaded by a garrotting stranger making the rounds about town, apparently striking only when it rains. The orphaned young woman and her new lover launch their own investigation and are endangered when a link is discovered with the victims and a particular operation performed years before. |
 |
Trauma Center: New Blood by Atlus At a remote hospital in Alaska, Dr. Markus Vaughn and his partner Valerie Blaylock work in a non-political environment, working only to heal and affect lives in a positive manner. When the facility unexpectedly closes they are forced to return to Concordia Medical Institute, where politics are more important than patients lives, and doctors more concerned with image than their ministration. They are recruited into the government organization Caduceus, where they will learn of a conspiracy with dire ramifications, and their lives will be changed forever. |
 |
Trauma and Recovery: The Aftermath of Violence--from Domestic Abuse to Political Terror by Judith Herman (Author) When Judith Herman's Trauma and Recovery was first published five years ago, it was hailed as a groundbreaking work. In the intervening years, Herman's now classic volume has changed the way we think about and treat traumatic events and trauma victims. In a new introduction, Herman chronicles the incredible response the book has elicited and explains how the issues surrounding the topic of trauma and recovery have shifted within the clinical community and the culture at large. Trauma and Recovery brings a new level of understanding to a set of problems usually considered individually. Herman draws on her own cutting-edge research on domestic violence, as well as on a vast literature of combat veterans and victims of political terror, to show the parallels between private terrors such as... |
 |
Healing from Trauma: A Survivor's Guide to Understanding Your Symptoms and Reclaiming Your Life by Jasmin Lee Cori (Author), Robert Scaer (Foreword) |
 |
Pilot Directed By: Peter Berg Also With: Peter Berg (Producer), Sarah Aubrey (Producer), Jeffrey Reiner (Producer), Peter Noah (Producer), Dario Scardapane (Producer), Dario Scardapane (Writer) |
 |
Trauma Starring: Colin Firth, Naomie Harris, Dorothy Duffy, Cornelius Booth, Dermot Murnaghan Directed By: Marc Evans Waking in a hospital bed ben learns that his wife was killed in the same car accident that put him in a coma for a week. His disorientation & feelings of guilt are amplified by the media frenzy gripping london following the murder of a pop star - a crime in which for some reasonhe seems implicated. Or is he? Studio: First Look Home Entertain Release Date: 09/02/2008 Starring: Colin Firth Mena Suvari Run time: 96 minutes Rating: R Director: Marc Evans |
 |
The Body Remembers: The Psychophysiology of Trauma and Trauma Treatment by Babette Rothschild (Author) Illuminates the value of understanding the psychophysiology of trauma for both clinicians and their traumatized clients. Traumatized people hold a memory of that trauma in their brains and bodies. This is the first book to link this phenomenon of somatic memory and the impact of trauma on the body. Reducing the chasm between scientific theory and clinical practice and bridging the gap between talk and body therapy, Rothschild presents techniques for addressing the memory in the body. |
 |
Trauma Center: Second Opinion by Atlus The follow-up to Trauma Center - Under the Knife, this is the first surgical video game for the Nintendo Wii. Sure, we've all imagined what it would be like to become a doctor. Years of medical school, residency, and clinic duty eventually pay off in a rewarding position saving people's lives. Or, you could skip all that and just put in a few hours after dinner. The critically acclaimed medical drama simulation is making a house call on your Wii! Dr. Derek Stiles is back, but he's not the only surgeon on call?a new player joins the team, bringing along everything the doctor ordered: difficulty modes, new surgical implements like the defibrillator, and an exciting never-before-seen conclusion. So what are you waiting for? If one dose of Trauma Center wasn't enough, it's time you got a... |
| © 2009 BrightSurf.com |